{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:51:36Z","timestamp":1793328696562,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obstructive sleep apnoea (OSA) induced chronic kidney disease is mainly caused by chronic intermittent hypoxia (CIH). Our study investigate the mechanism underlying CIH-induced renal damage and whether the cannabinoid receptor 1 (CB1R) antagonist rimonabant (Ri) alleviates CIH-induced renal injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Male Sprague-Dawley rats were randomly divided into five groups: one normal control (NC) group, two chronic intermittent hypoxia (CIH) groups, and two CIH\u2009+\u2009Ri groups. Rats in the NC groups were exposed to room air, while the CIH groups were exposed to a CIH environment for 4\u2009weeks (4w CIH group) and 6\u2009weeks (6w CIH group), respectively. Additionally, rats in the CIH\u2009+\u2009Ri groups were administered 1.5\u2009mg\/kg\/day Ri for 4\u2009weeks (4w CIH\u2009+\u2009Ri group) and 6\u2009weeks (6w CIH\u2009+\u2009Ri group), respectively. Following this, the rats were euthanized and kidneys were excised for downstream analysis. In the renal tissues, the morphological alterations were examined via haematoxylin eosin (HE) staining and periodic acid schiff (PAS) staining, CB1R, Fis1, Mfn1, and p66Shc expression was assessed through western blot and immunohistochemistry, and the mitochondrial ultrastructural changes in kidney sections were assessed by electron microscopy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CB1R expression in the 4w and 6w CIH groups was significantly elevated, and further increased with prolonged hypoxia; however, Ri prevented the increase in CIH-induced CB1R expression. Fis1 and p66Shc expression in the CIH groups were increased, but Mfn1 expression decreased. Ri decreased Fis1 and p66Shc expression and increased Mfn1 expression. Renal damage in the 4w or 6w CIH\u2009+\u2009Ri group was evidently improved compared with that in the 4w or 6w CIH group. CB1R expression was positively correlated with Fis1 and p66Shc and negatively correlated with Mfn1. Meanwhile, electron microscopy showed that the percentage of fragmented mitochondria in the tubular cells in each group was consistent with the trend of CB1R expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CIH causes endocannabinoid disorders and induces abnormal mitochondrial dynamics, resulting in renal injury. Treatment with CB1R antagonists reduces CIH-induced renal damage by inhibiting dysregulated renal mitochondrial dynamics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02362-6","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T20:05:01Z","timestamp":1619467501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats"],"prefix":"10.1186","volume":"22","author":[{"given":"Li","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-jun","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-xuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"8","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s2213-2600","volume":"7","author":"A Benjafield","year":"2019","unstructured":"Benjafield A, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687\u201398. https:\/\/doi.org\/10.1016\/s2213-2600.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"2362_CR2","first-page":"69","volume":"35","author":"DM Toraldo","year":"2015","unstructured":"Toraldo DM, De Nuccio F, De Benedetto M, Scoditti E. Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption. Acta Otorhinolaryngol Ital. 2015;35(2):69\u201374.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2362_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.smrv.2014.07.003","volume":"20","author":"L Lavie","year":"2015","unstructured":"Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia- revisited-the bad ugly and good: implications to the heart and brain. Sleep Med Rev. 2015;20:27\u201345. https:\/\/doi.org\/10.1016\/j.smrv.2014.07.003.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"2362_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1378\/chest.14-0500","volume":"147","author":"NA Dewan","year":"2015","unstructured":"Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities. Chest. 2015;147(1):266\u201374. https:\/\/doi.org\/10.1378\/chest.14-0500.","journal-title":"Chest."},{"issue":"10","key":"2362_CR5","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.107.189420","volume":"118","author":"VK Somers","year":"2008","unstructured":"Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease. Circulation. 2008;118(10):1080\u201311. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.189420.","journal-title":"Circulation."},{"issue":"1","key":"2362_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00043.2008","volume":"90","author":"JA Dempsey","year":"2010","unstructured":"Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47\u2013112. https:\/\/doi.org\/10.1152\/physrev.00043.2008.","journal-title":"Physiol Rev"},{"issue":"s1","key":"2362_CR7","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.3233\/JAD-179936","volume":"64","author":"AG Andrade","year":"2018","unstructured":"Andrade AG, Bubu OM, Varga AW, Osorio RS. The relationship between obstructive sleep apnea and Alzheimer's disease. J Alzheimers Dis. 2018;64(s1):S255\u2013S70. https:\/\/doi.org\/10.3233\/JAD-179936.","journal-title":"J Alzheimers Dis"},{"issue":"1112","key":"2362_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.5664\/jcsm.5274","volume":"15","author":"JJ Sheu","year":"2015","unstructured":"Sheu JJ, Lee HC, Lin HC, Kao LT, Chung SD. A 5-year follow-up study on the relationship between obstructive\u2002sleep\u2002apnea and Parkinson disease. J Clin Sleep Med. 2015;15(1112):1403\u20138. https:\/\/doi.org\/10.5664\/jcsm.5274.","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"2362_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.mayocp.2013.02.005.10","volume":"88","author":"A Alonso-Fern\u00e1ndez","year":"2013","unstructured":"Alonso-Fern\u00e1ndez A, de la Pe\u00f1a M, Romero D, Pi\u00e9rola J, Pi\u00e9rola J, Carrera M, et al. Association between obstructive sleep apnea and pulmonary embolism. Mayo Clin Proc. 2013;88(6):579\u201387. https:\/\/doi.org\/10.1016\/j.mayocp.2013.02.005.10.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"2362_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1378\/chest.08-2248","volume":"135","author":"JJ Sim","year":"2009","unstructured":"Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu ILA, Shi JM, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest. 2009;135(3):710\u20136. https:\/\/doi.org\/10.1378\/chest.08-2248.","journal-title":"Chest."},{"issue":"4","key":"2362_CR11","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1378\/chest.14-0596","volume":"146","author":"PJ Hanly","year":"2014","unstructured":"Hanly PJ, Ahmed SB. Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease? Chest. 2014;146(4):1114\u201322. https:\/\/doi.org\/10.1378\/chest.14-0596.","journal-title":"Chest."},{"key":"2362_CR12","doi-asserted-by":"publisher","unstructured":"Adams RJ, Appleton SL, Vakulin A, Hanly PJ, McDonald SP, Martin SA, et al. Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep. 2017;40. https:\/\/doi.org\/10.1093\/sleep\/zsw015.","DOI":"10.1093\/sleep\/zsw015"},{"issue":"3","key":"2362_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00421-011-2050-9","volume":"112","author":"WZ Zhu","year":"2012","unstructured":"Zhu WZ, Wu XF, Zhang Y, Zhou ZN. Proteomic analysis of mitochondrial proteins in cardiomyocytes from rats subjected to intermittent hypoxia. Eur J Appl Physiol. 2012;112(3):1037\u201346. https:\/\/doi.org\/10.1007\/s00421-011-2050-9.","journal-title":"Eur J Appl Physiol"},{"issue":"11","key":"2362_CR14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1681\/ASN.2013020126","volume":"24","author":"K Sharma","year":"2013","unstructured":"Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol. 2013;24(11):1901\u201312. https:\/\/doi.org\/10.1681\/ASN.2013020126.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2362_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ki.2012.441","volume":"83","author":"M Zhan","year":"2013","unstructured":"Zhan M, Brooks C, Liu F, Sun L, Dong Z. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int. 2013;83(4):568\u201381. https:\/\/doi.org\/10.1038\/ki.2012.441.","journal-title":"Kidney Int"},{"issue":"5","key":"2362_CR16","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","volume":"92","author":"DL Galvan","year":"2017","unstructured":"Galvan DL, Green NH, Danesh FR. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 2017;92(5):1051\u20137. https:\/\/doi.org\/10.1016\/j.kint.2017.05.034.","journal-title":"Kidney Int"},{"key":"2362_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.02.011","volume":"60","author":"SI Liochev","year":"2013","unstructured":"Liochev SI. Reactive oxygen species and the free radical theory of aging. FreeRadic Biol Med. 2013;60:1\u20134. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.02.011.","journal-title":"FreeRadic Biol Med"},{"issue":"1","key":"2362_CR18","doi-asserted-by":"publisher","first-page":"43811","DOI":"10.1038\/srep43811","volume":"7","author":"C Guo","year":"2017","unstructured":"Guo C, Wilkinson KA, Evans AJ, Rubin PP, Henley JM. SENP3-mediated deSUMOylation of Drp1 facilitates interaction with Mff to promote cell death. Sci Rep. 2017;7(1):43811. https:\/\/doi.org\/10.1038\/srep43811.","journal-title":"Sci Rep"},{"issue":"6","key":"2362_CR19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2337\/db05-1477","volume":"55","author":"S Menini","year":"2006","unstructured":"Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, et al. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes. 2006;55(6):1642\u201350. https:\/\/doi.org\/10.2337\/db05-1477.","journal-title":"Diabetes."},{"issue":"5","key":"2362_CR20","doi-asserted-by":"publisher","first-page":"F1014","DOI":"10.1152\/ajprenal.00414.2010","volume":"299","author":"L Sun","year":"2010","unstructured":"Sun L, Xiao L, Nie J, Liu FY, Ling GH, Zhu XJ, et al. p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway. Am J Physiol Renal Physiol. 2010;299(5):F1014\u201325. https:\/\/doi.org\/10.1152\/ajprenal.00414.2010.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"2362_CR21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1042\/cs20180005","volume":"132","author":"M Zhan","year":"2018","unstructured":"Zhan M, Usman I, Yu J, Ruan L, Bian X, Yang J, et al. Perturbations in mitochondrial dynamics by p66Shc lead to renal tubular oxidative injury in human diabetic nephropathy. Clin Sci (Lond). 2018;132(12):1297\u2013314. https:\/\/doi.org\/10.1042\/cs20180005.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2362_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/dom.13497","volume":"21","author":"A Drori","year":"2019","unstructured":"Drori A, Permyakova A, Hadar R, Udi S, Nemirovski A, Tam J. Cannabinoid-1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells. Diabetes Obes Metab. 2019;21(1):146\u201359. https:\/\/doi.org\/10.1111\/dom.13497.","journal-title":"Diabetes Obes Metab"},{"key":"2362_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/238482","volume":"238482","author":"C Sharma","year":"2015","unstructured":"Sharma C, Sadek B, Goyal SN, Sinha S, Kamal MA, Ojha S. Small molecules from nature targeting G-protein coupled cannabinoid receptors: potential leads for drug discovery and development. Evid Based Complement Alternat Med. 2015;238482:1\u201326. https:\/\/doi.org\/10.1155\/2015\/238482.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"2362_CR24","doi-asserted-by":"publisher","first-page":"e89566","DOI":"10.1371\/journal.pone.0089566","volume":"9","author":"JM McPartland","year":"2014","unstructured":"McPartland JM, Guy GW, Di Marzo V. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS One. 2014;9(3):e89566. https:\/\/doi.org\/10.1371\/journal.pone.0089566.","journal-title":"PLoS One"},{"issue":"5","key":"2362_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MNH.0000000000000249","volume":"25","author":"DH Hryciw","year":"2016","unstructured":"Hryciw DH, McAinch AJ. Cannabinoid receptors in the kidney. Curr Opin Nephrol Hypertens. 2016;25(5):459\u201364. https:\/\/doi.org\/10.1097\/MNH.0000000000000249.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2362_CR26","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/db09-1336","volume":"59","author":"F Barutta","year":"2010","unstructured":"Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, et al. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. Diabetes. 2010;59(4):1046\u201354. https:\/\/doi.org\/10.2337\/db09-1336.","journal-title":"Diabetes."},{"issue":"1","key":"2362_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mce.2013.09.001","volume":"382","author":"JF Briffa","year":"2014","unstructured":"Briffa JF, Grinfeld E, McAinch AJ, Poronnik P, Hryciw DH. Short term exposure to elevated levels of leptin reduces proximal tubule cell metabolic activity. Mol Cell Endocrinol. 2014;382(1):38\u201345. https:\/\/doi.org\/10.1016\/j.mce.2013.09.001.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2362_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ki.2015.63","volume":"88","author":"L Lecru","year":"2015","unstructured":"Lecru L, Desterke C, Grassin-Delyle S, Chatziantoniou C, Vandermeersch S, Devocelle A, et al. Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney Int. 2015;88(1):72\u201384. https:\/\/doi.org\/10.1038\/ki.2015.63.","journal-title":"Kidney Int"},{"key":"2362_CR29","doi-asserted-by":"publisher","unstructured":"Calik MW, Carley DW. Effects of cannabinoid agonists and antagonists on sleep and breathing in Sprague-Dawley rats. Sleep. 2017;40(9). https:\/\/doi.org\/10.1093\/sleep\/zsx112.","DOI":"10.1093\/sleep\/zsx112"},{"issue":"4","key":"2362_CR30","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s11325-019-02009-9","volume":"24","author":"ZJ Dou","year":"2020","unstructured":"Dou ZJ, Gao XL, Jia YL, Chen J, Yang JJ, Chen Y, et al. CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats. Sleep Breath. 2020;24(4):1441\u20139. https:\/\/doi.org\/10.1007\/s11325-019-02009-9.","journal-title":"Sleep Breath"},{"issue":"8","key":"2362_CR31","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1172\/JCI15623","volume":"110","author":"VY Melnikov","year":"2002","unstructured":"Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanvic D, Edelstein CL. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest. 2002;110(8):1083\u201391. https:\/\/doi.org\/10.1172\/JCI15623.","journal-title":"J Clin Invest"},{"key":"2362_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9782031","volume":"9782031","author":"X Wang","year":"2016","unstructured":"Wang X, Yu Q, Yue H, Zhang J, Zeng S, Cui F. Circulating endocannabinoids and insulin resistance in patients with obstructive sleep apnea. Biomed Res Int. 2016;9782031:1\u20138. https:\/\/doi.org\/10.1155\/2016\/9782031.","journal-title":"Biomed Res Int"},{"issue":"6","key":"2362_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/embj.201386474","volume":"33","author":"MJ Baker","year":"2014","unstructured":"Baker MJ, Lampe PA, Stojanovski D, Korwitz A, Anand R, Tatsuta T, et al. Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics. EMBO J. 2014;33(6):578\u201393. https:\/\/doi.org\/10.1002\/embj.201386474.","journal-title":"EMBO J"},{"issue":"10","key":"2362_CR34","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.2337\/db07-1781","volume":"58","author":"AJ Molina","year":"2009","unstructured":"Molina AJ, Wikstrom JD, Stiles L, Las G, Mohamed H, Elorza A, et al. Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. Diabetes. 2009;58(10):2303\u201315. https:\/\/doi.org\/10.2337\/db07-1781.","journal-title":"Diabetes."},{"issue":"12","key":"2362_CR35","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nrm3013","volume":"11","author":"B Westermann","year":"2010","unstructured":"Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 2010;11(12):872\u201384. https:\/\/doi.org\/10.1038\/nrm3013.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2362_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1042\/BST20150274","volume":"44","author":"G Kanfer","year":"2016","unstructured":"Kanfer G, Kornmann B. Dynamics of the mitochondrial network during mitosis. Biochem Soc Trans. 2016;44(2):510\u20136. https:\/\/doi.org\/10.1042\/BST20150274.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2362_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10456-016-9530-9","volume":"20","author":"Z Hu","year":"2017","unstructured":"Hu Z, Cheng J, Xu J, Ruf W, Lockwood CJ. Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy. Angiogenesis. 2017;20(1):85\u201396. https:\/\/doi.org\/10.1007\/s10456-016-9530-9.","journal-title":"Angiogenesis."},{"issue":"4","key":"2362_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-017-0630-5","volume":"112","author":"M Rienks","year":"2017","unstructured":"Rienks M, Carai P, Bitsch N, Schellings M, Vanhaverbeke M, Verjans J, et al. Sema3A promotes the resolution of cardiac inflammation after myocardial infarction. Basic Res Cardiol. 2017;112(4):42. https:\/\/doi.org\/10.1007\/s00395-017-0630-5.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"2362_CR39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.18632\/aging.100017","volume":"1","author":"M Gertz","year":"2009","unstructured":"Gertz M, Fischer F, Leipelt M, Wolters D, Steegborn C. Identification of eroxiredoxin 1 as a novel interaction partner for the lifespan regulator protein p66Shc. Aging (Albany NY). 2009;1(2):254\u201365. https:\/\/doi.org\/10.18632\/aging.100017.","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"2362_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/ars.2010.3147","volume":"13","author":"M Gertz","year":"2010","unstructured":"Gertz M, Steegborn C. The lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor? Antioxid Redox Sign. 2010;13(9):1417\u201328. https:\/\/doi.org\/10.1089\/ars.2010.3147.","journal-title":"Antioxid Redox Sign"},{"issue":"2","key":"2362_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","volume":"122","author":"M Giorgio","year":"2005","unstructured":"Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005;122(2):221\u201333. https:\/\/doi.org\/10.1016\/j.cell.2005.05.011.","journal-title":"Cell."},{"issue":"5812","key":"2362_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1135380","volume":"315","author":"P Pinton","year":"2007","unstructured":"Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, et al. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science. 2007;315(5812):659\u201363. https:\/\/doi.org\/10.1126\/science.1135380.","journal-title":"Science."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02362-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02362-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02362-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T20:05:05Z","timestamp":1619467505000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02362-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02362-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Ethics Committee of the Science and Technology Department of The Second Hospital of Shanxi Medical University, China and implemented in accordance with regulations of the People\u2019s Republic of China on Animal Management. The study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}